Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders.
CEO
Mr. Stephen R. DavisGlassdoor
Employee Ratings4 / 528 reviews
72% recommend to a friend
$4B
Market Cap • 02/06/20231993
(30 years ago)
2004
(19 years ago)
San Diego
Headquarters • California513
Employees • 2022Valuation
Company FinancialsValuation Indicators
Valuation Indicators| Year | Equity | Revenue | EBITDA | Fin. Res. | Net Inc. | Net Mar. | ROE | Cash | Debt | N.D. / EBITDA | OCF | CAPEX | FCF | Free | Div. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/23 TTM | 374 | 520 | -162 | 10 | -146 | L | L | 403 | 61 | L | -56 | 0 | 7 | -56 | 0 |
The values above are represented in USD and the scale is in millions—10.000 is the equivalent of 10 billions. L inside the table means Loss.